Antipsychotic Agents: all 1,683 studies that test it
Page 15 of 17. Open to participants first (95), then studies with results posted, then the rest; newest registration first within each.
- The Impact of Quetiapine on the Drug Abuse Patterns of Addicted Schizophrenic PatientsCompletedNCT00295412Phase 4
- Risperidone Plus Mood Stabilizer in Treatment of Mixed ManiaCompletedNCT00294255Phase 4
- A Study of Aripiprazole in Patients With Schizophrenia in General Psychiatric PracticesCompletedNCT00292409Phase 3
- Appetite Increase in Schizophrenia Patients Treated With Atypical AntipsychoticsCompletedNCT00290121Phase 4
- Randomized Double-blind Trial of Midazolam and Loxapine in Agitated PatientsTerminatedNCT00290082Phase 3
- Risperidone Augmentation in Patients With SchizophreniaCompletedNCT00289861Phase 4
- Comparative Effects of Chronic Treatment With Olanzapine and Risperidone on Glucose and Lipid MetabolismCompletedNCT00287820Phase 4
- A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Patients With Hallucinations and Delusions Associated With Alzheimer's DiseaseTerminatedNCT00287742Phase 3
- Study of Amantadine for Weight Stabilization During Olanzapine TreatmentCompletedNCT00287352Phase 1
- Aripiprazole in the Treatment of Acutely Relapsed Patients With SchizophreniaCompletedNCT00283179Phase 3
- Aripiprazole in the Treatment of Tourette's SyndromeTerminatedNCT00282139Not applicable
- Dopaminergic Modulation of Choroidal Blood Flow Changes During Dark/Light TransitionsCompletedNCT00280501Not applicable
- Study of Quetiapine Monotherapy in Ambulatory Bipolar Spectrum Disorder With Moderate-to-Severe Hypomanic Symptoms or Mild Manic SymptomsCompletedNCT00277667Phase 3
- Study of Risperidone Monotherapy in Ambulatory Bipolar Disorder With Concurrent Moderately Severe Anxiety and Lifetime Panic or Generalized Anxiety DisorderCompletedNCT00277654Phase 3
- Aripiprazole Augmentation Therapy in Treatment-resistant DepressionWithdrawnNCT00276978Phase 3
- Aripiprazole to Reduce Cocaine RelapseCompletedNCT00276874Phase 1
- Olanzapine Augmentation Therapy in Treatment-resistant Depression: a Double-blind Placebo-controlled TrialWithdrawnNCT00273624Phase 3
- Risperidone LA Heathcare Resource StudyCompletedNCT00272597Phase 4
- CARE Study: Improving Treatment for the Most Severely Ill With SchizophreniaCompletedNCT00272584Phase 4
- A Phase 1 Parallel-Group, Double-Blind, Placebo-Controlled Cardiovascular and Behavioral Study Assessing Interactions Between Single Doses of Oral Reserpine and Intravenous Methamphetamine - 1Status unknownNCT00267657Phase 1
- A Study of the Safety and Effectiveness of Risperidone Versus Placebo for the Treatment of Conduct Disorder in Children With Mild, Moderate, or Borderline Mental RetardationCompletedNCT00266552Phase 3
- Study Evaluating SCA-136 in Subjects With Acute Exacerbations of SchizophreniaCompletedNCT00265551Phase 2
- A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Children With Autistic Disorder and Other Pervasive Developmental Disorders (PDD)CompletedNCT00261508Phase 3
- SB-773812 Administered In Adults With SchizophreniaCompletedNCT00259870Phase 2
- Study of Aripiprazole in Patients With Bipolar I DisorderCompletedNCT00257972Phase 3
- A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic Episodes Associated With Bipolar I DisorderCompletedNCT00257075Phase 3
- An Exploratory Study on the Safety and Effectiveness of Paliperidone in Patients With SchizophreniaCompletedNCT00257023Phase 2
- Seroquel® Combined With Cognitive Remediation Therapy to Conventional Treatment in Patients With SchizophreniaCompletedNCT00255515Phase 4
- A Prospective Study of Risperdal (Risperidone) for the Treatment of Behavioral Disorder Following Psychological Therapy for Challenging Behavior in Learning Disabled ChildrenCompletedNCT00254930Phase 3
- Fast Titration Of Quetiapine Versus Currently Approved TitrationCompletedNCT00254813Phase 3
- Verkes Borderline Study: The Effect of Quetiapine on Borderline Personality Disordered PatientsCompletedNCT00254748Phase 2
- Quetiapine Augmentation in Severe Obsessive Compulsive DisorderCompletedNCT00254735Phase 3
- Safety and Efficacy of Seroquel in First Episode SchizophreniaCompletedNCT00254241Phase 4
- Venlafaxine Augmentation in Treatment Resistant DepressionCompletedNCT00253266Phase 4
- A Study of the Effectiveness and Safety of Risperidone Compared With Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder, and the Maintenance of Anti-manic Effectiveness of Risperidone Compared With HaloperidolCompletedNCT00253162Phase 3
- A Study of the Effectiveness and Safety of Risperidone as add-on Therapy to Mood Stabilizers in the Treatment of Manic Episodes Associated With Bipolar DisorderCompletedNCT00253149Phase 3
- A Study of the Effectiveness and Safety of Long-acting Injectable Risperidone Versus Placebo in the Treatment of Patients With SchizophreniaCompletedNCT00253136Phase 3
- A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Behavioral Disturbances in Patients With DementiaCompletedNCT00253123Phase 3
- A Comparison of Risperidone With Haloperidol in Patients With Schizophrenia and Schizoaffective DisorderCompletedNCT00253110Phase 4
- Quetiapine (Seroquel) Maintenance Treatment in Early Onset Bipolar Spectrum DisordersCompletedNCT00252226Phase 3
- A Study to Evaluate the Safety and Efficacy of Clozapine in Patients With Treatment-resistant SchizophreniaCompletedNCT00250575Phase 3
- A Study of the Effectiveness and Safety of Risperidone Versus Placebo as add-on Therapy to Mood Stabilizers, in the Treatment of Manic Episodes Associated With Bipolar Disorder.CompletedNCT00250367Phase 3
- A Study of the Safety and Effectiveness of Risperidone for the Treatment of Conduct Disorder and Other Disruptive Behavior Disorders in Children Ages 5 to 12 With Mild, Moderate, or Borderline Mental RetardationCompletedNCT00250354Phase 3
- Post-operative Haloperidol Versus Placebo for Prevention of Post-operative Delirium After Acute Hip SurgeryCompletedNCT00250237Phase 3
- A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic or Mixed Episodes Associated With Bipolar I DisorderCompletedNCT00249236Phase 3
- A Study of Risperidone in Combination With Lorazepam Compared With Standard Therapy for Emergency Treatment of Schizophrenic PatientsCompletedNCT00249171Phase 4
- A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With DementiaCompletedNCT00249158Phase 3
- A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With DementiaCompletedNCT00249145Phase 3
- A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol and Placebo in Patients With Chronic SchizophreniaCompletedNCT00249132Phase 3
- A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol in Patients With Chronic SchizophreniaCompletedNCT00249119Phase 3
- A Study of the Effectiveness and Safety of Risperidone in the Treatment of Adolescents With SchizophreniaCompletedNCT00246285Phase 3
- An Open-label Study Evaluating the Maintenance of Clinical Effect in Adult Schizophrenia Patients Switched From Risperidone Tablets to an Equivalent Dose of a Rapidly-dissolving Tablet Formulation of RisperdoneCompletedNCT00246272Phase 3
- A Randomized, Open-label Trial of Long-acting Injectable Risperidone Versus Oral Antipsychotic Medication in Patients With Bipolar DisorderCompletedNCT00246246Phase 3
- SOLIACS: Solian Solution in the Acute SettingCompletedNCT00245674Phase 4
- Side Effects of Newer Antipsychotics in Older AdultsCompletedNCT00245206Phase 4
- A Study of the Efficacy and Safety of Long-acting Injectable Risperidone and Risperidone Tablets in Patients With SchizophreniaCompletedNCT00240708Phase 3
- Ziprasidone Versus Olanzapine In The Treatment Of Schizophrenia.CompletedNCT00239109Phase 4
- A Study of Aripiprazole in the Management of Patients With Schizophrenia in the General Psychiatric PracticesCompletedNCT00237939Phase 3
- Schizophrenia Trial of AripiprazoleCompletedNCT00237913Phase 3
- Aripiprazole Treatment of Prodromal PatientsCompletedNCT00237874Phase 2/3
- Quetiapine Treatment for Post-Traumatic Stress Disorder (PTSD)CompletedNCT00237393Phase 4
- A Long Term Study of Long-acting Injectable Risperidone in the Treatment of Patients With SchizophreniaCompletedNCT00236587Phase 3
- Evaluation of the Usefulness to Doctors of the Risperdal Consta Treatment Guidebook Over a Three-month Period During Which Adult Patients With Schizophrenia or Schizoaffective Disorder Are Switching From Daily Doses or Risperidone Tablets to Long-acting Risperidone by InjectionCompletedNCT00236548Phase 3
- A Study of the Safety of Risperidone in the Treatment of Children and Adolescents With Conduct and Other Disruptive Behavior DisordersCompletedNCT00236470Phase 3
- A Study Comparing the Efficacy of Long-acting Injectable Risperidone and Olanzapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective DisorderCompletedNCT00236457Phase 3
- A Study of the Efficacy and Safety of Risperidone in the Prevention of Relapse in Children and Adolescents With Conduct and Other Disruptive Behavior DisordersCompletedNCT00236444Phase 3
- A Study of the Effects of Risperidone and Olanzapine on Blood Glucose (Sugar) in Patients With Schizophrenia or Schizoaffective DisorderCompletedNCT00236379Phase 4
- Evaluation of the Efficacy and Safety of Risperidone Injections Given Once a Month to Adults With Schizophrenia or Schizoaffective DisorderCompletedNCT00236353Phase 3
- Seroquel Switching Study: Feasibility of Switching Any Antipsychotic Treatment to Seroquel in Patients With SchizophreniaCompletedNCT00234377Phase 3
- A Switch Study of BMS-337039 in Schizophrenic Out-patientsCompletedNCT00232687Phase 4
- Quetiapine for the Treatment of Insomnia in Alzheimer's DiseaseStatus unknownNCT00232570Not applicable
- A Double-Blind Randomized Placebo Controlled Study of Quetiapine for the Treatment of Depression in Adolescents With Bipolar DisorderCompletedNCT00232414Phase 3
- Quetiapine for Cocaine Use and CravingsCompletedNCT00232336Phase 4
- Quetiapine Decreases Smoking in Patients With Chronic SchizophreniaStatus unknownNCT00231101Not applicable
- A Double Blind, Randomized Placebo Controlled Study of the Efficacy, Safety and of Quetiapine Fumarate (Seroquel®) as Potentiation SSRI's, and SNRI's Treatment in Major Depression With AnxietyCompletedNCT00229645Phase 4
- Treatment With Ziprasidone for Schizophrenia Patients With Obsessive Compulsive Disorder (OCD)CompletedNCT00229385Not applicable
- Relapse Prevention, RoW: Study to Evaluate Prevention of Relapse in Patients in Stable Chronic Schizophrenia Receiving Either Seroquel or PlaceboCompletedNCT00228462Phase 3
- A Randomized Control Trial Comparing Quetiapine to Risperidone in Bipolar Disorder With Stimulant DependenceCompletedNCT00227123Not applicable
- Aripiprazole in the Treatment of Bipolar DepressionCompletedNCT00226317Not applicable
- The Effects of Aripiprazole on Patients With Metabolic SyndromeCompletedNCT00224822Phase 4
- Clozapine-Augmentation With Ziprasidone or Risperidone, a Randomized, Prospective TrialCompletedNCT00224315Phase 4
- Study Comparing Patients Taking Olanzapine and Patients Taking Aripiprazole on Learning of Vocational SkillsCompletedNCT00223418Not applicable
- Quetiapine in Patients With Bipolar and Alcohol Abuse/DependenceCompletedNCT00223249Phase 4
- An Add-On Trial of Quetiapine in Patients With Bipolar Disorder and Cocaine DependenceCompletedNCT00223210Phase 4
- The Effect of Switching to Aripiprazole on Heart Health in Overweight and Obese Patients With SchizophreniaCompletedNCT00222833Phase 4
- Study of Aripiprazole (Abilify) in Children With ADHD (Attention Deficit Hyperactivity Disorder)CompletedNCT00221962Phase 4
- A Study of Quetiapine for the Treatment of Mood Disorders in AdolescentsCompletedNCT00221468Phase 3
- An Open-Label Trial of Aripiprazole in Children and Adolescents With Bipolar DisorderCompletedNCT00221416Phase 3
- A Study of Treatment Success in Changing From Olanzapine to Long-acting Injectable Risperidone (RISPERDAL® CONSTA™)CompletedNCT00216632Phase 4
- The Safety and Efficacy of Risperidone as Adjunctive Therapy to Mood Stabilizers in the Long-term Treatment of Bipolar ManiaCompletedNCT00216554Phase 4
- A Study to Evaluate Symptomatic Remission in Schizophrenia With Long Acting Risperidone MicrospheresCompletedNCT00216528Phase 4
- Quetiapine in Social Anxiety DisorderCompletedNCT00215254Phase 2/3
- Risperidone Augmentation for PTSDCompletedNCT00215241Phase 2/3
- Seroquel on Glucose MetabolismCompletedNCT00214578Phase 4
- Efficacy and Safety of Asenapine Compared With Olanzapine in Patients With Persistent Negative Symptoms of Schizophrenia (25543)(COMPLETED)(P05817)CompletedNCT00212836Phase 3
- Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)CompletedNCT00212784Phase 3
- Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25520)(P05846)CompletedNCT00212771Phase 3
- Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (SFBRI)TerminatedNCT00211380Not applicable
- Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (BMS)TerminatedNCT00211302Not applicable
- A Study to Compare the Effectiveness and Safety of Flexibly Varied Doses of Paliperidone Palmitate and Risperidone in Treating Patients With SchizophreniaCompletedNCT00210717Phase 3